Skip to content

Brimonidine 2-oxo and 3-oxo (1:1) Impurity

Brimonidine 2-oxo and 3-oxo (1:1) Impurity

Product Description
CAT No.
ALN-B026048
CAS No.
NA
Mol. F.
C11H10BrN5O
Mol. Wt.
308.1
Stock
Please Inquire
Chemical Name : 5-Bromo-6-((4,5-dihydro-1H-imidazol-2-yl)amino)quinoxalin-2(1H)-one compound with 8-bromo-7-((4,5-dihydro-1H-imidazol-2-yl)amino)quinoxalin-2(1H)-one (1:1)
Smiles : O=C1NC2=C(C(Br)=C(NC3=NCCN3)C=C2)N=C1.O=C4NC5=C(C=CC(NC6=NCCN6)=C5Br)N=C4
Inchi : InChI=1S/C14H15F3N2O2/c15-11-8-13(17)12(16)6-9(11)5-10(18)7-14(20)19-1-3-21-4-2-19/h6-8H,1-5,18H2/b10-7-

Sustained reduction of intraocular pressure by supraciliary delivery of brimonidine-loaded poly(lactic acid) microspheres for the treatment of glaucoma

B.Chianga1Y.C.Kimb1A.C.Dotyc12H.E.GrossniklausdS.P.SchwendemancM.R.PrausnitznJournal of Controlled Release Volume 228, 28 April 2016, Pages 48-57

Sustained release of brimonidine from a new composite drug delivery system for treatment of glaucoma

Jianguo Sun, Yuan Lei, Zhaoxing Dai∥, Xi Liu, Taomin Huang, Jihong Wu, Zhi Ping XOrcid, and Xinghuai Sun – ACS Appl. Mater. Interfaces 2017, 9, 9, 7990–7999

A validated stability-indicating HPLC method for determination of brimonidine tartrate in BRI/PHEMA drug delivery systems

Jianguo Sun, Xiuwen Zhang & Taomin Huang – Chemistry Central Journal volume 11, Article number: 62 (2017)

Request For Quotation